338 filings
Page 5 of 17
8-K
2625kp5yko7z64u0c2
5 Aug 11
Ardea Biosciences Reports Recent Accomplishments and Second Quarter 2011 Financial Results
12:00am
CORRESP
licisppfvapb1r
2 Aug 11
Correspondence with SEC
12:00am
UPLOAD
jux5cdwsm2dgzi4en
19 Jul 11
Letter from SEC
12:00am
8-K
bayp69jn n9qznaeixt
25 May 11
Departure of Directors or Certain Officers
12:00am
8-K
srh18z71r82 2e74l
9 May 11
Ardea Biosciences Reports Recent Accomplishments and Announces First Quarter 2011 Financial Results
12:00am
ARS
br8bwor1 rrsk3ml1j
15 Apr 11
Annual report to shareholders
12:00am
DEFR14A
lk4f406hzqf7g3ojt6mu
12 Apr 11
Revised proxy
12:00am
8-K
jedmf6
8 Apr 11
Departure of Directors or Certain Officers
12:00am
8-K
o82ihga7bmoi3wnkm6
11 Mar 11
Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
12:00am
424B5
rsfi 723m
21 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
ojh6izwnqfgvykda9gqh
21 Jan 11
Ardea Biosciences Prices Public Offering of Common Stock
12:00am
8-K
6srl nhgv70sta8q
19 Jan 11
Results of Operations and Financial Condition
12:00am
424B5
3q1qvj8w 900wpt30w
19 Jan 11
Prospectus supplement for primary offering
12:00am
8-K
opp8m
10 Jan 11
Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
12:00am
8-K
gxkhafkpncet355
6 Jan 11
Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
12:00am
8-K
149iykf
21 Dec 10
Departure of Directors or Certain Officers
12:00am